GlobeNewswire

Radient Technologies Inc. Provides Update on Progress of Cannabis and Hemp Extraction Facilities and Issues Shares for Services

Share

EDMONTON, Alberta, June 20, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF) is pleased to announce it has awarded the mandate for the second phase of the construction of its Edmonton III manufacturing facility to Fillmore Construction Management Inc. (“Fillmore”). Construction is well underway, with footings and foundation work having been completed, and the structural component of the building now in progress and on schedule. Fillmore was selected by Radient due to its extensive previous experience developing food processing and GMP approved manufacturing plants.

Edmonton III is Radient’s expanded capacity cannabis and hemp processing line that is expected to have a total annual throughput capacity of 280,000 kg/year of cannabis, and 2,800,000 kg/year of hemp upon completion in calendar 2020.

Radient completed its first commercial extraction run for Aurora Cannabis Inc. (“Aurora”) (TSX: ACB; NYSE: ACB) in May 2019 at its Edmonton I Facility, which has an annual throughput capacity of at least 56,000 kg of cannabis/year. Radient will continue to scale up its operations at Edmonton I throughout the summer, expecting to reach full capacity at this facility in late 2019.

Additionally, the ongoing retrofitting of Edmonton II, Radient’s dedicated hemp processing line, which is expected to have a total annual throughput capacity of 420,000 kg/year of hemp, is on schedule for completion in calendar Q4, 2019.

Foundation work has also now begun on Radient’s brand new 100,000+ sq. ft. facility in Germany. This facility is expected to have a total annual throughput capacity in excess of 280,000 kg/year of cannabis, and 2,800,000 kg/year of hemp upon completion in calendar 2020.

For a comprehensive overview of Radient’s total expected future annual throughput capacities in Edmonton and Germany, please see the Company’s press release dated February 28, 2019.

Shares for Services

Radient has issued an aggregate of 86,658 common shares to third party consultants for services provided during the month ended May 31, 2019, pursuant to the Shares for Service Agreement previously approved by the TSX Venture Exchange.

The common shares were issued at the TSX Venture Exchange 15-day VWAP share price of CAD $0.96.

About Radient 
Radient Technologies provides industrial-scale manufacturing solutions for premium natural ingredients and products. Utilizing its patented MAP™ extraction technology, Radient delivers superior customer outcomes in terms of ingredient purity, yield, and cost, serving global market leaders in industries such as foods & beverages, nutraceuticals, pharmaceuticals, cosmetics, and personal care. Since 2016, Radient has expanded its offerings to enter the cannabinoids market, using its MAP™ platform to provide premium ingredients that contain a full range of cannabinoid and terpene profiles. Please visit www.radientinc.com for more information.

SOURCE: Radient Technologies Inc.

For investors: William (Bill) Wasson, Senior VP of Capital Markets and Investor Relations: wwasson@radientinc.com

For Media: Caitlin Cheadle, Director of Communications: ccheadle@radientinc.com

Forward Looking Information:
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding the growth of the Company’s business operations; the construction of the Company’s facilities; the expected throughput capacities at its facilities; the issuance of shares for services; the Company’s ability to grow its business in the cannabis sector and the Company’s future plans. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Radient, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although Radient has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Radient does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

ContextVision announces first digital pathology patent granted for its unique and objective data-generation method21.11.2019 17:00:00 CETPress release

STOCKHOLM – November 21, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, announce today that its proprietary Master Annotation method has received patent protection in the U.S. The U.S. Patent and Trademark Office (USPTO) has granted a patent to ContextVision for this invention, titled “method and system for detecting pathological anomalies in a digital pathology image and method for annotating a tissue slide”. ContextVision developed this method to automatically and more objectively outline specific structures in pathology images used for training deep learning algorithms. It identifies and highlights cancer areas and other structures by using multi-plex immunofluorescent staining. This enables development of algorithms based on objective data with high accuracy. “This patent protection is a milestone for ContextVision, and I´m so happy and proud to see this idea become reality. Thanks to a strong team effort we h

Avance Gas – Invitation to Earnings Release Audio Webcast for the Third Quarter of 201921.11.2019 15:46:00 CETPress release

Bermuda, 21 November 2019 - Avance Gas Holding Ltd (OSE: "AVANCE"), will on Tuesday 26 November 2019 release its unaudited results for the third quarter of 2019. In connection with the earnings release, an audio webcast and conference call will be held at 15:00 (CET). The webcast can be accessed at Avance Gas’ website www.avancegas.com. Dial in details are +44 (0) 2071 928 000 (UK and International), +1 631 510 7495 (US) or +47 23 96 02 64 (Norway). Please quote the passcode: 8359635. Phone lines will open 10 minutes before the conference call. For further queries, please contact: Peder C. G. Simonsen, CFO Tel: +47 22 00 48 15 Email: p.simonsen@avancegas.com ABOUT AVANCE GAS Avance Gas Holding Ltd operates in the global market for transportation of liquefied petroleum gas (LPG). The Company is one of the world's leading owners and operators of very large gas carriers (VLGCs), operating a fleet of 14 modern VLGC. For more information about Avance Gas, please visit: www.avancegas.com Thi

SDLP - Seadrill Partners LLC Announces Third Quarter 2019 Results21.11.2019 12:49:00 CETPress release

Highlights Operating revenue of $184.8 million Operating income of $13.0 million Net loss of $54.2 million Adjusted EBITDA of $91.9 million Cash and cash equivalents of $653.6 million Economic utilization of 95% Order backlog of $512 million as of November 21, 2019 1 cent per common unit distribution for the third quarter of 2019 Financial Results Overview Total operating revenues for the third quarter were $184.8 million (2Q19: $178.5 million). The increase was primarily due to a full quarter of operations for the West Aquarius and West Capricorn, the West Auriga returning to normal operations, the West Polaris commencing its contract in Gabon and the early termination fee received for the West Vencedor. These were partially offset by early termination fees for the West Capricorn received in the second quarter not being repeated, idle time on the West Capella prior to the commencement of a new contract in September and a full quarter of idle time on the T-16 tender barge. Total operat